PRELUDE CAPITAL MANAGEMENT, LLC

Position in SHC — Sotera Health Co

CIK 1387508 NEW YORK, NY

Position in SHC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,699,632

+$2,142,194 QoQ

Shares Held

208,430

+91.9% QoQ

Ownership

0.073%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

#83

of 318 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $9,382,081 across 8 Diagnostics & Research names. SHC ranks #1 (39.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SHC	Sotera Health Co This page	208,430	$3,699,632
2	TMO	Thermo Fisher Scientific Inc.	5,752	$2,883,822
3	FLGT	Fulgent Genetics, Inc.	51,698	$1,060,842
4	IDXX	Idexx Laboratories Inc /De	809	$425,889
5	DHR	Danaher Corp /De/	2,072	$394,674
6	NTRA	Natera, Inc.	1,428	$387,630
7	LH	Labcorp Holdings Inc.	1,130	$316,400
8	GH	Guardant Health, Inc.	1,421	$213,192

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,699,632	208,430	+91.9%	Shares	Other	2026-08-14
2026-03-31	$1,557,438	108,608	+375.3%	Shares	Other	2026-05-15
2025-12-31	$403,109	22,852	+127.2%	Shares	Other	2026-02-17
2025-09-30	$158,243	10,060	-9.2%	Shares	Other	2025-11-14
2024-12-31	$151,574	11,080	-64.3%	Shares	Other	2025-02-14
2024-09-30	$518,201	31,030	+52.5%	Shares	Other	2024-11-14
2024-06-30	$241,495	20,345	-11.0%	Shares	Other	2024-08-14
2024-03-31	$274,500	22,856	-52.0%	Shares	Other	2024-05-15
2022-12-31	$397,024	47,662	+20.2%	Shares	Other	2023-02-14
2021-12-31	$933,851	39,654	-54.6%	Shares	Other	2022-02-14
2021-09-30	$2,285,065	87,383	+1.7%	Shares	Sole	2021-11-15
2021-06-30	$2,082,568	85,950	-6.1%	Shares	Sole	2021-08-16
2021-03-31	$2,284,089	91,510	—	Shares	Other	2021-05-17
No filing history on record for this holder in this stock.